Stem Cell Treatments for Heart Disease is an Option
Cardiovascular diseases remain the biggest cause of deaths worldwide, though over the last two decades, cardiovascular mortality rates have declined in many high-income countries but have increased at an astonishingly fast rate in low- and middle-income countries. The percentage of premature deaths from cardiovascular disease range from 4% in high-income countries to 42% in low-income countries. More than 17 million people died from cardiovascular diseases in 2008. Each year, heart disease kills more Americans than cancer. In recent years, cardiovascular risk in women has been increasing and has killed more women than breast cancer.
Measures to prevent cardiovascular disease may include:
- Keeping unapposed simple carbohydrates under control, no matter what type: fruit, bread, dairy, etc.
- decrease emotional stress, or how you react to the environment (traffic, work, deadlines, lifestyle, etc.)
- a low fat high fiber diet including whole grains and plenty of fresh fruit and vegetables (at least five portions a day)
- a diet high in complex vegetables and colorful fruit
- tobacco cessation;
- limit alcohol consumption;
- lower blood pressures if elevated through diet and exercise;
- decrease body fat (BMI);
- increase daily activity to 30 minutes of any kind of exercise per day at least five times per week
A fairly recent emphasis is on the link between low-grade inflammation that hallmarks atherosclerosis and its possible interventions. C-reactive protein (CRP) is a common inflammatory marker that has been found to be present in increased levels in patients at risk for cardiovascular disease. Also osteoprotegerin which is involved with regulation of a key inflammatory transcription factor called NF-κB has been found to be a risk factor of cardiovascular disease and mortality. Studies have shown that Stem Cells have shown the ability to reduce inflammation.
Stem Cell Treatments for Heart Disease is an Option at ASCI
Streaming NIH Database:
Related Articles Molecular Imaging in stem cell-based therapies of cardiac diseases. Adv Drug Deliv Rev. 2017 Jul 19;: Authors: Li X, Hacker M Abstract In the past 15years, despite regenerative medicine has shown great potential for cardiovascular diseases, the outcome and safety of stem cell transplantation has shown controversial results in the published literature. Medical imaging might be useful for monitoring and quantification transplanted cells within the heart and to serially characterize the effects of stem cell therapy of the myocardium. From the multiple available noninvasive imaging techniques, magnetic resonance imaging and nuclear imaging by positron (PET) or single photon emission computer tomography (SPECT) are the most used clinical approaches to follow the fate of transplanted stem cells in vivo. In this article, we provide a review on the role of different noninvasive imaging modalities and discuss their advantages and disadvantages. We focus on the different in-vivo labeling and reporter gene imaging strategies for stem cell tracking as well as the concept and reliability to use imaging parameters as noninvasive surrogate endpoints for the evaluation of the post-therapeutic outcome. PMID: 28734900 [PubMed - as supplied by publisher]Read more...